Effects of Fast Bar on Intermittent Fasting

NCT ID: NCT04790552

Last Updated: 2021-09-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

89 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-01

Study Completion Date

2021-08-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates how Fast Bar(TM), a specially formulated energy bar, when consumed with coffee or tea, affects the physiological condition in participants after an overnight fasting. Participants will fast for 19 hours (Fast Group), consume a Fast Bar in the night (Night Bar Group) or in the morning (Bar+Coffee and Bar+Tea Groups) after an approximately 15-hour overnight fasting. Participants will be assessed for physiological parameters associated with fasting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Interest in fasting-based programs (i.e. intermittent fasting) for improvement of health and longevity continues to grow. The short-term fasting (e.g. 12 to 48 hours in duration) utilized in many intermittent fasting programs are considered safe, but some individuals may find them subjectively difficult. As such, the question of whether the benefits of fasting can be obtained while small amounts of food are consumed is of substantial interest.

One commercially available product that is designed to be consumed during periods of intermittent fasting is the Fast Bar™, which stems out of the well-researched fasting-mimicking diet to assist prolonged fasting. The unique formulation of the Fast Bar™ is hypothesized to minimize deviations in metabolic biomarkers associated with a fasting state. This may ease the burdens associated with extended period of fasting. The objective of this study is to evaluate the metabolic and subjective effects of Fast Bar, when consumed with coffee or tea, after a prolonged period of fasting.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fasting

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fast Group

Subjects will be asked to consume a standardized ready-to-eat dinner meal before 5 pm on day 1. Subjects will fast overnight for approximately 19 hours.

Group Type ACTIVE_COMPARATOR

Dinner

Intervention Type OTHER

Study subjects will consume a standardized ready-to-eat meal as dinner.

Fasting

Intervention Type OTHER

Subjects will be asked to fast overnight for approximately 15 hours.

Night Bar Group

Subjects will be asked to consume a standardized ready-to-eat dinner meal before 5 pm on day 1. Subjects will consume a Fast Bar 3 hours after the dinner and then fast overnight. Subjects will fast overnight for approximately 15 hours and then consume a Fast Bar with coffee on day 2.

Group Type EXPERIMENTAL

Dinner

Intervention Type OTHER

Study subjects will consume a standardized ready-to-eat meal as dinner.

Fasting

Intervention Type OTHER

Subjects will be asked to fast overnight for approximately 15 hours.

Fast Bar

Intervention Type OTHER

Subjects will be asked to consume a Fast Bar.

Bar + Coffee Group

Subjects will be asked to consume a standardized ready-to-eat dinner meal before 5 pm on day 1. Subjects will fast overnight for approximately 15 hours and then consume a Fast Bar with coffee on day 2.

Group Type EXPERIMENTAL

Dinner

Intervention Type OTHER

Study subjects will consume a standardized ready-to-eat meal as dinner.

Fasting

Intervention Type OTHER

Subjects will be asked to fast overnight for approximately 15 hours.

Bar with Coffee

Intervention Type OTHER

Subjects will be asked to consume a Fast Bar with coffee.

Bar + Tea Group

Subjects will be asked to consume a standardized ready-to-eat dinner meal before 5 pm on day 1. Subjects will fast overnight for approximately 15 hours and then consume a Fast Bar with tea on day 2.

Group Type EXPERIMENTAL

Dinner

Intervention Type OTHER

Study subjects will consume a standardized ready-to-eat meal as dinner.

Fasting

Intervention Type OTHER

Subjects will be asked to fast overnight for approximately 15 hours.

Bar with Tea

Intervention Type OTHER

Subjects will be asked to consume a Fast Bar with tea.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dinner

Study subjects will consume a standardized ready-to-eat meal as dinner.

Intervention Type OTHER

Fasting

Subjects will be asked to fast overnight for approximately 15 hours.

Intervention Type OTHER

Fast Bar

Subjects will be asked to consume a Fast Bar.

Intervention Type OTHER

Bar with Coffee

Subjects will be asked to consume a Fast Bar with coffee.

Intervention Type OTHER

Bar with Tea

Subjects will be asked to consume a Fast Bar with tea.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ability and willingness to provide written informed consent;
* Ability and willingness to use Zoom teleconference;
* Ability and willingness to perform the study tests and adhere to study protocol to the best of the participant's knowledge;
* 18-65 years of age (inclusive) at screening;
* BMI 20-35 kg/m2 (inclusive) at screening;
* In good health (as determined by medical history to evaluate acute or ongoing chronic medical diagnoses/conditions that have been present for at least 90 days);
* Habitual breakfast eater (determined with a screening survey: number of breakfasts per week ≥4.

Exclusion Criteria

* Has any medical disease or condition that, in the opinion of the principal investigator (PI) or appropriate study personnel, precludes study participation\* (\*Including acute, subacute, intermittent or chronic medical disease or condition that would place the subject at an unacceptable risk of injury, render the subject unable to meet the requirements of the protocol, or may interfere with the evaluation of responses or the subject's successful completion of this trial);
* History of gastric bypass (based on medical history provided at screening);
* Under medications aimed at keeping blood glucose under control (based on medical history provided at screening);
* Type 1 diabetes (based on medical history provided at screening);
* Taking insulin, insulin analogs, or octreotide (based on medical history provided at screening);
* Food allergies which would make the subject unable to consume the food provided (based on medical history and information provided at screening) (participants will be asked to review the ingredient lists for the dinner meal and the Fast BarTM, and to state that they are not allergic to the ingredients to the best of their knowledge);
* Women who are pregnant;
* Alcohol dependency (alcohol intake greater than two drinks per day for women and three drinks per day for men) (based on medical history and information provided at screening).
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

L-Nutra Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

William Hsu, MD

Role: PRINCIPAL_INVESTIGATOR

L-Nutra Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

L-Nutra Inc.

Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20210458

Identifier Type: OTHER

Identifier Source: secondary_id

LN002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.